article

1. Assessment of arterial pulsatility of cerebral perforating arteries using 7T high-resolution dual-VENC phase-contrast MRI..  Magnetic resonance in medicine.  92:605-617. 2024
2. Association Between Self- and Proxy-Reported Depression and Quality of Life in Mild-Moderate Alzheimer's Disease..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  32:58-67. 2023
3. Decreased functional connectivity is associated with increased levels of Cerebral Spinal Fluid soluble-PDGFRβ, a marker of blood brain barrier breakdown, in older adults..  Research square.  2023
4. Impact of non-binding FDA guidances on primary endpoint selection in Alzheimer's disease trials..  Alzheimer's & dementia (New York, N. Y.).  8:-. 2022
5. Barriers to seeking care for memory problems: A vignette study..  Alzheimer's & dementia (New York, N. Y.).  8:-. 2022
6. Medicare's Annual Wellness Visit and diagnoses of dementias and cognitive impairment..  Alzheimer's & dementia (Amsterdam, Netherlands).  14:-. 2022
7. The small HDL particle hypothesis of Alzheimer's disease..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  19:391-404. 2022
8. Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults..  Brain, behavior, and immunity.  299-307. 2021
9. Cerebral Amyloid Angiopathy-related Inflammation Presenting With a Cystic Lesion in Young-onset Alzheimer Disease..  Alzheimer disease and associated disorders.  35:265-268. 2021
10. Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid..  The Journal of neuroscience : the official journal of the Society for Neuroscience.  40:8573-8586. 2020
11. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline..  Nature.  581:71-76. 2020
12. A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  16:821-830. 2020
13. Cognitive symptoms of Alzheimer's disease: clinical management and prevention..  BMJ (Clinical research ed.).  -. 2019
14.  
15.